Yatin Suneja

Stock Analyst at Guggenheim

(4.93)
# 188
Out of 4,988 analysts
439
Total ratings
54.3%
Success rate
28.7%
Average return

Stocks Rated by Yatin Suneja

First Tracks Biotherapeutics
Sep 17, 2026
Initiated: Buy
Price Target: $100
Current: $39.00
Upside: +156.41%
Sionna Therapeutics
Sep 16, 2026
Maintained: Hold
Price Target: n/a
Current: $7.31
Upside: -
Roivant Sciences
Sep 9, 2026
Reiterated: Buy
Price Target: $42$46
Current: $34.18
Upside: +34.58%
Alumis
Sep 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $10.35
Upside: -
Latigo Biotherapeutics
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $21.77
Upside: +129.67%
Spyre Therapeutics
Aug 26, 2026
Reiterated: Buy
Price Target: $130
Current: $87.05
Upside: +49.34%
Cabaletta Bio
Aug 13, 2026
Reiterated: Buy
Price Target: $16
Current: $3.57
Upside: +348.18%
Zenas BioPharma
Aug 13, 2026
Reiterated: Buy
Price Target: $55
Current: $33.13
Upside: +66.01%
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: $70
Current: $14.24
Upside: +391.57%
Zura Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $15$20
Current: $5.67
Upside: +252.73%
Reiterated: Buy
Price Target: $200
Current: $91.63
Upside: +118.27%
Maintained: Buy
Price Target: $260$275
Current: $209.92
Upside: +31.00%
Reiterated: Buy
Price Target: $35
Current: $15.05
Upside: +132.56%
Reiterated: Buy
Price Target: $100
Current: $39.48
Upside: +153.29%
Reiterated: Buy
Price Target: $90
Current: $60.16
Upside: +49.60%
Reiterated: Buy
Price Target: $50$48
Current: $19.34
Upside: +148.19%
Reiterated: Buy
Price Target: $800
Current: $357.50
Upside: +123.78%
Maintained: Buy
Price Target: $45
Current: $12.02
Upside: +274.38%
Reiterated: Buy
Price Target: $200
Current: $106.24
Upside: +88.25%
Initiated Coverage: Buy
Price Target: $1,135$1,185
Current: $1,055.37
Upside: +12.28%
Maintained: Buy
Price Target: $1,000$1,030
Current: $852.03
Upside: +20.89%
Maintained: Buy
Price Target: $200$222
Current: $157.79
Upside: +40.69%
Maintained: Buy
Price Target: $25$22
Current: $9.26
Upside: +137.58%
Rated: Buy
Price Target: $260$280
Current: $222.67
Upside: +25.75%
Reiterated: Buy
Price Target: $51
Current: $13.61
Upside: +274.72%
Reiterated: Buy
Price Target: $175
Current: $111.08
Upside: +57.54%
Reiterated: Buy
Price Target: $68
Current: $4.79
Upside: +1,319.62%
Maintained: Buy
Price Target: $44$62
Current: $39.49
Upside: +57.00%
Maintained: Buy
Price Target: $15
Current: $3.75
Upside: +300.00%
Maintained: Buy
Price Target: $14
Current: $2.29
Upside: +511.35%
Maintained: Buy
Price Target: $60
Current: $30.50
Upside: +96.72%
Maintained: Buy
Price Target: $14
Current: $1.38
Upside: +914.49%
Maintained: Buy
Price Target: $128$100
Current: $9.35
Upside: +969.52%
Reiterated: Buy
Price Target: $140
Current: $55.88
Upside: +150.54%
Maintained: Buy
Price Target: $20
Current: $15.06
Upside: +32.80%
Reiterated: Hold
Price Target: n/a
Current: $37.49
Upside: -
Reiterated: Buy
Price Target: $26
Current: $3.87
Upside: +571.83%
Maintained: Hold
Price Target: $20
Current: $28.93
Upside: n/a
Upgraded: Buy
Price Target: $45
Current: $22.60
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $13.59
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Downgraded: Hold
Price Target: n/a
Current: $0.107
Upside: n/a
Initiated Coverage: Buy
Price Target: $24
Current: $18.00
Upside: n/a
Reiterated: Buy
Price Target: $9
Current: $1.29
Upside: n/a
Reiterated: Buy
Price Target: $115$123
Current: $34.13
Upside: n/a
Initiated Coverage: Buy
Price Target: $12
Current: $1.04
Upside: n/a
Reiterated: Buy
Price Target: $21$32
Current: $18.54
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $56.90
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $18.86
Upside: n/a